Chemours CC Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.38B+3.9% | $1.33B-11.1% | $1.5B-7.4% | $1.62B+18.1% | $1.37B+0.7% | ||
| $1.17B-0.4% | $1.17B-7.0% | $1.26B-5.6% | $1.34B+18.1% | $1.13B+3.5% | ||
| $212M+36.8% | $155M-33.5% | $233M-16.2% | $278M+17.8% | $236M-10.9% | ||
| 15.4%+3.7pp | 11.7%-3.9pp | 15.6%-1.6pp | 17.2%0.0pp | 17.3%-2.2pp | ||
| $26M-3.7% | $27M+3.8% | $26M-7.1% | $28M+3.7% | $27M+3.8% | ||
| $147M+13.1% | $130M+6.6% | $122M-71.2% | $424M+245% | $123M-27.6% | ||
| $79M-2.5% | $81M+1.3% | $80M-12.1% | $91M+3.4% | $88M+18.9% | ||
| $186M+15.5% | $161M+5.9% | $152M-67.7% | $470M+157% | $183M-10.3% | ||
| $69M+1.5% | $68M0.0% | $68M+1.5% | $67M+1.5% | $66M-1.5% | ||
| $22M+633% | $3M-81.3% | $16M+700% | $2M-60.0% | $5M— | ||
| $8M0.0% | $8M-11.1% | $9M0.0% | $9M+12.5% | $8M-11.1% | ||
| -$9M— | —— | —— | —— | $0+100% | ||
| -$22M+67.2% | -$67M-276% | $38M+115% | -$248M— | $0-100% | ||
| $7M— | —— | -$8M-106% | $131M+2,520% | $5M-58.3% | ||
| -$29M+38.3% | -$47M-202% | $46M+112% | -$380M-7,500% | -$5M+54.5% | ||
| -2.1%+1.4pp | -3.5%-6.6pp | 3.1%+26.6pp | -23.5%-23.2pp | -0.4%+0.4pp | ||
| -$0.19+38.7% | -$0.31-200% | $0.31+112% | -$2.53-8,333% | -$0.03+62.5% | ||
| -$0.19+38.7% | -$0.31-200% | $0.31+112% | -$2.53-8,333% | -$0.03+62.5% | ||
| $3M+50.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $27M+440% | $5M+150% | $2M— | $0-100% | $26M— | ||
| -$11M— | —— | —— | $111M+893% | -$14M— | ||
| —— | —— | $7M— | —— | $1M— | ||
| $6M— | —— | $7M-22.2% | $9M+28.6% | $7M— | ||
| -$19M+48.6% | -$37M-640% | -$5M+81.5% | -$27M+52.6% | -$57M— | ||
| -$44M-2.3% | -$43M-22.9% | -$35M+16.7% | -$42M+51.2% | -$86M+19.6% | ||
| -$44M-132% | $137M-6.2% | $146M+57.0% | $93M+183% | -$112M— | ||
| $22M+633% | $3M-81.3% | $16M+700% | $2M-60.0% | $5M— | ||
| -$14M— | —— | $5M— | —— | $37M+223% | ||
| $10M+233% | $3M— | —— | —— | —— | ||
| $49M+8.9% | $45M+9.8% | $41M-4.7% | $43M-48.8% | $84M-22.9% | ||
| $7M— | —— | $6M— | —— | —— | ||
| $13M+225% | $4M0.0% | $4M-77.8% | $18M-45.5% | $33M+313% | ||
| $1.38B+3.9% | $1.33B-11.1% | $1.5B-7.4% | $1.62B+18.1% | $1.37B+0.7% | ||
| $47M+4,600% | $1M-99.1% | $106M+159% | -$181M-374% | $66M-2.9% | ||
| $126M+53.7% | $82M-55.9% | $186M+307% | -$90M-158% | $154M+8.5% | ||
| $126M+53.7% | $82M-55.9% | $186M+307% | -$90M-158% | $154M+8.5% | ||
| 9.1%+3.0pp | 6.2%-6.3pp | 12.4%+18.0pp | -5.6%-16.8pp | 11.3%+0.8pp | ||
| $47M+4,600% | $1M-99.1% | $106M+159% | -$181M-374% | $66M-2.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Chemours's income statement data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.